Chong Kun Dang Pharmaceutical Corp. (185750.KS) KSC

82,200.00

-800(-0.96%)

Updated at August 18 03:30PM

Currency In KRW

Chong Kun Dang Pharmaceutical Corp.

Address

8, Chungjeong-ro

Seoul,

Korea, Republic of

Phone

82 2 2194 0300

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

2276

First IPO Date

December 06, 2013

Key Executives

NameTitlePayYear Born
Mr. Young-Joo KimPresident, Chief Executive Officer & Chairman0N/A

Description

Chong Kun Dang pharmaceutical Corp. engages in the manufacturing, marketing, and selling of medicines in South Korea and internationally. It provides prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetics; over-the-counter drugs, such as Penzal, Prefemine, and Modcol, as well as consumer health products, such as insecticides, hair dye, etc.; and healthcare supplements with preventive benefits. The company also exports its products. Chong Kun Dang pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.